Document is current
Any future updates will be listed below
-
Authors
Gjyrezi, Ada https://orcid.org/0000-0002-4145-7117
Galletti, Giuseppe https://orcid.org/0000-0002-1920-5554
Zhang, Jiaren
Worroll, Daniel https://orcid.org/0000-0001-7351-676X
Sigouros, Michael https://orcid.org/0000-0002-0328-8359
Kim, Seaho
Cooley, Victoria
Ballman, Karla V.
Ocean, Allyson J.
Shah, Manish A. https://orcid.org/0000-0002-6913-9655
Scandura, Joseph M. https://orcid.org/0000-0002-9525-143X
Sboner, Andrea
Nanus, David M.
Beltran, Himisha https://orcid.org/0000-0003-3259-2226
Tagawa, Scott https://orcid.org/0000-0003-2777-8587
Giannakakou, Paraskevi https://orcid.org/0000-0001-7378-262X
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWh-19-1-0666)
- License Information
-
More Information
Article History
Received: 28 March 2020
Accepted: 3 June 2021
First Online: 24 June 2021
Competing interests
: A.G., S.K., and P.G. have a pending patent application for the AR-V7 and ARv567es ddPCR assays. A.J.O. reports having served as a consultant for Celgene and Tyme. M.A.S. reports having served as a consultant/advisory board member for Merck and received research funding from Gilead, Boston Biomedical, Bristol Meyers Squib, and Merck. K.V.B. reports being a DSMB member of Takeda trial and expert witness for Johnson & Johnson, Sanofi, and Janssen Oncology. H.B. reports having served as a consultant/advisory board member for Janssen, Astella, Sanofi Genzyme, Pfizer, Astra Zeneca, Merck and has received research funding from Jansen Oncology (Inst), Abb Vie/Stemcentrx, Eli Lilly (Inst). D.M.N. reports being a DSMB member for Genentech Roche. S.T. reports receiving honorarium for consulting for Genomic Health. G.G., J.Z., D.W., M.S., J.S., V.C., and A.S. have nothing to disclose.
